Assessing the Comparative Outcomes From Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.864
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV